MAP3K2, a member of the MAP3K family, plays a pivotal role in the IL-18/MAP3K2/JNK pathway, which is essential for T-cell immunity in the intestine and shows promise as a new target for intervention in T-cell-mediated colitis [38]. This evidence concerns the gene MAP3K2 and colitis.